Continued">Continued">Continued">Hospital 57357 joins the 3rd Emirati BMT forum – Children Cancer Hospital Egypt 57357

Hospital 57357 joins the 3rd Emirati BMT forum

    Hospital 57357 participated in the third Emirati Conference for Bone Marrow Transplantation and Gene Therapy for Children. The hospital’s participation was initiated by the Continuing Education and Development Department with the aim of marketing the training programs it offers. Furthermore, the delegation from Hospital 57357 highlighted the development of all consultative services provided by the … Continued

Hospital 57357 participated in the third Emirati Conference for Bone Marrow Transplantation and Gene Therapy for Children. The hospital’s participation was initiated by the Continuing Education and Development Department with the aim of marketing the training programs it offers. Furthermore, the delegation from Hospital 57357 highlighted the development of all consultative services provided by the Hospital in Egypt and the Arab world. This reflects the Hospital’s commitment to providing the best medical care for children and supporting innovations in the field of gene therapy.

During the conference, the participation of Hospital 57357 was welcomed by Dr. Zain al-Abidin, the conference consultant, head of the Department of Hematology, Oncology, and Pediatric Bone Marrow Transplantation at Burjeel Medical City. Hospital 57357 was honored in recognition of its participation in the conference.

On the sidelines of the conference, Dr. Zain al-Abidin invited Hospital 57357’s delegation to visit Burjeel Hospital. A tour of the various departments was conducted, and discussions took place regarding future cooperation in various fields of research and child treatment.

This participation represents an opportunity to strengthen cooperation between 57357 and medical institutions in the region, thereby contributing to improving the level of healthcare and developing new treatment techniques. It also underscores Hospital 57357’s commitment to continuing to provide the best treatments for children at the Arab and global levels.